C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2004
11/10/2004	CN1544631A Dehydrin gene BcDh2 and the application of promoter in cultivation of drought resistant plants
11/10/2004	CN1544625A Method for construction of bombyx mori virus fast gene expression system utilizing bacterium transposon
11/10/2004	CN1544624A Double promoter DNA vaccine expression vector pCMVnir and preparation method thereof
11/10/2004	CN1544619A Method for preparing puerarin using hairly pueraria phaseoloides
11/10/2004	CN1544618A Biotransformation method for resting cell in cloud point system
11/10/2004	CN1544091A Melanocyte suspension and its preparation for treating leukodermia
11/10/2004	CN1175111C Method for integrating genes at specific sites in mammalian cells and vector used in it
11/10/2004	CN1175107C DNA molecules of encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutant thereof
11/09/2004	US6815594 Inbred corn line G1202
11/09/2004	US6815593 Genetic engineered plant; uniform particles
11/09/2004	US6815592 Inbred maize line PH3AV
11/09/2004	US6815581 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/09/2004	US6815540 Improved solubility/yield/ease of handling; fusion proteins; for diagnostics/drugs/research
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815531 For diagnosis/therapy of autoimmune diseases; antitumor agents; drugs; cytotoxic t-lymphocytes
11/09/2004	US6815427 Sericin-containing material, process for producing the same method of using the same
11/09/2004	US6815420 Methods of using chemokine beta-6
11/09/2004	US6815416 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/09/2004	US6815205 Auxinic analogues of indole-3-acetic acid
11/09/2004	US6815203 Methods of making pancreatic islet cells
11/09/2004	US6815202 A homogenous cell mixture spontaneously sorting to form discrete first and second layers, e.g. keratinocytes and fibroblasts, and having a connective tissue component; skin grafts: testing a response to a chemical or a drug
11/09/2004	US6815194 Cytidine deaminase
11/09/2004	US6815193 Protease for use in treating textiles, cleaning agents and animal feeds
11/09/2004	US6815190 Having improved thermostability; used in the enzymatic hydrolysis of cyclic oligomers of poly(ethylene terephthalate) in the finishing of yarn or fabric from fibers
11/09/2004	US6815185 Methods of creating constructs useful for introducing sequences into embryonic stem cells
11/09/2004	US6815184 Generating preferential polypeptide in plant; obtain plant cells, transform with vector containing preferential polypeptide, express vector, recover polypeptide
11/09/2004	US6815171 Two-domain mhc polypeptides include mhc( major histocompatibility complex) class ii-based molecules that covalently linked beta 1 and alpha 1 domains, and mhc class i-based molecules that covalently linked alpha-1 and alpha-2
11/09/2004	US6815159 Generation of viral protease; obtain polypeptide, incubate with chaotropic agent, fold, recover protease
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	CA2274596C Compositions and methods for enhancing intestinal function
11/09/2004	CA2273080C Mutants of the lag-3 proteins, products for the expression of these mutants and use
11/09/2004	CA2151231C Human cyclooxygenase-2cdna and assays for evaluating cyclooxygenase-2 activity
11/09/2004	CA2074363C Co2-independent growth medium for maintenance and propagation of cells
11/05/2004	CA2464979A1 Embryogenic culture initiation of douglas fir by maltose
11/04/2004	WO2004094988A2 Tolerance to graft prior to thymic regeneration
11/04/2004	WO2004094654A2 Transfection kinetics and structural promoters
11/04/2004	WO2004094649A2 Tolerance to graft following thymic reactivation
11/04/2004	WO2004094637A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004	WO2004094633A1 Process for producing recombinant protein in bacterium belonging to the genus rhodococcus
11/04/2004	WO2004094628A1 Imanitib-resistant philadelphia chromosome-positive human acute lymphocytic leukemic cell line and utilization thereof
11/04/2004	WO2004094627A1 Method for improving germline transmission efficiency of avian primordial germ cells
11/04/2004	WO2004094626A1 Pva-based polymer coating for cell culture
11/04/2004	WO2004094625A1 Uv-cross-linked pva-based polymer particles for cell culture
11/04/2004	WO2004094619A2 Hematopoietic stem cells treated by in vitro fucosylation and methods of use
11/04/2004	WO2004094611A2 Reprogramming nuclear function with somatic cell cytoplasm
11/04/2004	WO2004094610A2 Wnt as a factor for cardiac myogenesis
11/04/2004	WO2004094602A2 Combinatorial surface chip compositions for selection, differentiation and propagation of cells
11/04/2004	WO2004094599A2 Disease prevention and vaccination following thymic reactivation
11/04/2004	WO2004094598A2 Methods of use for novel human polypeptides encoded by polynucleotides
11/04/2004	WO2004094597A2 Anthozoan fluorescent protein genes
11/04/2004	WO2004094596A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/04/2004	WO2004094590A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/04/2004	WO2004094588A2 Postnatal stem cells and uses thereof
11/04/2004	WO2004094586A2 Three-dimentional, flexible cell growth substrate and related methods
11/04/2004	WO2004094476A2 Compositions and methods relating to stop-1
11/04/2004	WO2004093934A2 Materials and methods for augmenting and/or repairing intervertebral discs
11/04/2004	WO2004093830A2 Model for neurodegenerative disorders
11/04/2004	WO2004093788A2 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004	WO2004093658A2 Improved methods and solutions for storing donor organs
11/04/2004	WO2004083372A3 Modulators of the notch signaling pathway immobilized on particles for modifying immune responses
11/04/2004	WO2004081167A3 Expression vectors comprising the mcmv ie2 promoter
11/04/2004	WO2004061077A3 Increasing gamete production with a gene switch
11/04/2004	WO2004053095A3 In situ maturation of dendritic cells
11/04/2004	WO2004052177A3 Cell-based therapies for ischemia
11/04/2004	WO2004050827A3 Cultured human pancreatic islets, and uses thereof
11/04/2004	WO2004047747A3 Compositions and methods for cell dedifferentiation and tissue regeneration
11/04/2004	WO2004045493A3 Methods of inducing or enhancing cartilage repair
11/04/2004	WO2004035537A3 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
11/04/2004	WO2004030628A3 Adult bone marrow derived stem cells
11/04/2004	WO2004027043A3 Method for production of a multimeric protein by cell fusion
11/04/2004	WO2004024227A3 Systems of sperm cell preservation and processing
11/04/2004	WO2004011484A3 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
11/04/2004	WO2004002223A3 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
11/04/2004	WO2003102135A3 Control sequences of the human corin gene
11/04/2004	WO2003100026A3 Methods, compositions, and growth and differentiation factors for insulin-producing cells
11/04/2004	WO2003092612A3 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE
11/04/2004	WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/04/2004	WO2003087115A3 Oligomeric compounds having modified phosphate groups
11/04/2004	WO2003076473A8 Specific ab1'-antibodies against tumour-associated antigen ca 125
11/04/2004	WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004	WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004	WO2003004616A3 Dendritic cell isolation methods
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	WO2000039557A3 Devices, methods and systems for collecting material from a breast duct
11/04/2004	US20040221336 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/04/2004	US20040221330 Preparing genetically engineered plant comprising vector with modified upstream regulatory sequences for use as tool in heterologous gene expression in plants; bioreactors; tissue engineering
11/04/2004	US20040220619 Method of inhibiting the proliferation of vascular smooth muscle cells
11/04/2004	US20040220535 Transferring materials into cells porous silicon
11/04/2004	US20040220396 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
11/04/2004	US20040220125 Biosynthetic platform for cardioprotective gene expression using immature heart tissue
11/04/2004	US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004	US20040220106 Modified vitamin K-dependent polypeptides
11/04/2004	US20040220096 Method and compositions for treating dopaminergic and gabanergic disorders
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220088 Multiple domain glycoprotein hormones and methods of using
11/04/2004	US20040220082 Parkinson's disease; central nervous system disorders; reducing activation of Kv3.4 protein
11/04/2004	US20040219676 Methods and compositions for the introduction of molecules into cells
11/04/2004	US20040219672 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells
11/04/2004	US20040219670 Surface layer providing the substrate with topographical features with nanoscale dimension, having the capacity to adapt, facilitate, influence, control or inhibit at least one cell or tissue behavior or response thereon and/or therebetween
11/04/2004	US20040219669 Method for detection of hemopoietic stem and progenitor cells

1 ... 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 ... 1827